• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观点对垒:宫颈癌筛查指南——即将步入黄金时代。

Counterpoint: cervical cancer screening guidelines--approaching the golden age.

出版信息

Am J Epidemiol. 2013 Oct 1;178(7):1023-6; discussion 1027. doi: 10.1093/aje/kwt171. Epub 2013 Aug 21.

DOI:10.1093/aje/kwt171
PMID:23966564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3783099/
Abstract

Changes in screening guidelines that imply suppression of procedures once recommended are always controversial because of the perception that benefits are being curtailed. Prior to 2012, cervical cancer screening guidelines issued by US-based expert bodies differed in several decision areas, making clinicians essentially cherry-pick among recommendations. To some extent, this approach to screening practices also served to shield clinicians from litigation. It implied starting screening earlier, doing it more frequently, and stopping later in life than necessary. This state of affairs changed in 2012, when the most influential professional groups updated their cervical screening guidelines, and recommendations became essentially unified. All groups recommended that women older than 65 years of age discontinue cervical cancer screening on the basis of evidence that screening benefits in this age group were minor and far outweighed by harms. The guidelines are very specific about the exceptions, which ensure acceptable safety. It is expected that the new guidelines will permit less wasteful cervical screening, while fostering the opportunity to direct resources towards ensuring adequate coverage of high-risk women.

摘要

筛查指南的变化暗示着曾经推荐的程序被抑制,这总是会引起争议,因为人们认为这会减少获益。在 2012 年之前,美国专家机构发布的宫颈癌筛查指南在几个决策领域存在差异,这使得临床医生基本上可以在建议中进行选择。在某种程度上,这种筛查方法也有助于保护临床医生免受诉讼。这意味着筛查开始得更早,更频繁,而且在生命后期停止得更早,这是不必要的。这种情况在 2012 年发生了变化,当时最有影响力的专业团体更新了他们的宫颈癌筛查指南,建议基本上变得统一了。所有团体都建议,年龄大于 65 岁的妇女应该根据证据停止宫颈癌筛查,因为该年龄组的筛查获益较小,而危害远远超过获益。这些指南非常具体地说明了例外情况,以确保可接受的安全性。预计新指南将减少浪费性的宫颈癌筛查,同时为确保高危妇女得到充分覆盖提供机会。

相似文献

1
Counterpoint: cervical cancer screening guidelines--approaching the golden age.观点对垒:宫颈癌筛查指南——即将步入黄金时代。
Am J Epidemiol. 2013 Oct 1;178(7):1023-6; discussion 1027. doi: 10.1093/aje/kwt171. Epub 2013 Aug 21.
2
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.接种人乳头瘤病毒疫苗女性的最佳宫颈癌筛查
J Natl Cancer Inst. 2016 Oct 18;109(2). doi: 10.1093/jnci/djw216. Print 2017 Feb.
3
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines.美国癌症中心的公共宫颈癌筛查建议:评估对国家指南的遵循情况。
J Med Screen. 2024 Sep;31(3):201-204. doi: 10.1177/09691413241238960. Epub 2024 Mar 20.
4
Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.宫颈癌筛查退出资格:国家队列与安全网队列的比较
Gynecol Oncol. 2021 Aug;162(2):308-314. doi: 10.1016/j.ygyno.2021.05.035. Epub 2021 Jun 3.
5
Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.按年龄划分的宫颈癌筛查和发病情况:接近和超过筛查停止年龄后的未满足需求。
Am J Prev Med. 2017 Sep;53(3):392-395. doi: 10.1016/j.amepre.2017.02.024. Epub 2017 May 1.
6
Cervical cancer screening in the era of human papillomavirus testing and vaccination.人乳头瘤病毒检测和疫苗接种时代的宫颈癌筛查。
J Midwifery Womens Health. 2012 Nov-Dec;57(6):569-576. doi: 10.1111/j.1542-2011.2012.00207.x. Epub 2012 Oct 10.
7
Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.法医学事务。国际细胞学会特别工作组总结。《迈向21世纪的诊断细胞学:一次国际专家会议及教程》
Acta Cytol. 1998 Jan-Feb;42(1):76-119; discussion 120-32. doi: 10.1159/000331537.
8
Screening for breast and cervical cancer: understanding the different recommendations.乳腺癌和宫颈癌筛查:了解不同的建议。
Nurs Womens Health. 2013 Aug-Sep;17(4):331-5. doi: 10.1111/1751-486X.12052.
9
Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.初级保健中的宫颈癌筛查:美国预防服务工作组的决策分析。
JAMA. 2018 Aug 21;320(7):706-714. doi: 10.1001/jama.2017.19872.
10
No. 385-Indications for Pelvic Examination.第385号——盆腔检查的适应症
J Obstet Gynaecol Can. 2019 Aug;41(8):1221-1234. doi: 10.1016/j.jogc.2018.12.007.

引用本文的文献

1
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.评估美国三个医疗环境中宫颈癌筛查异常结果的管理情况以及与指南建议的一致性。
Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):912-922. doi: 10.1158/1055-9965.EPI-23-1564.
2
Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.扩大宫颈癌筛查的年龄上限:一项全国性非随机干预研究方案。
BMJ Open. 2020 Nov 5;10(11):e039636. doi: 10.1136/bmjopen-2020-039636.
3
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.基于 HPV 和细胞学联合检测的现有指南,满足条件的女性中宫颈癌前病变的绝对风险。
Int J Cancer. 2020 Feb 1;146(3):617-626. doi: 10.1002/ijc.32268. Epub 2019 Apr 8.
4
Automated recommendation for cervical cancer screening and surveillance.宫颈癌筛查与监测的自动化推荐
Cancer Inform. 2014 Oct 15;13(Suppl 3):1-6. doi: 10.4137/CIN.S14035. eCollection 2014.
5
Cervical cancer screening in older women: new evidence and knowledge gaps.老年女性的宫颈癌筛查:新证据与知识空白
PLoS Med. 2014 Jan;11(1):e1001586. doi: 10.1371/journal.pmed.1001586. Epub 2014 Jan 14.
6
Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.50至64岁的宫颈癌筛查与65岁及以上人群患宫颈癌的风险:基于人群的病例对照研究。
PLoS Med. 2014 Jan;11(1):e1001585. doi: 10.1371/journal.pmed.1001585. Epub 2014 Jan 14.

本文引用的文献

1
Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.观点:宫颈癌筛查指南应考虑在老年女性中观察到的筛查效果数据。
Am J Epidemiol. 2013 Oct 1;178(7):1020-2. doi: 10.1093/aje/kwt167. Epub 2013 Aug 21.
2
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.不同年龄阶段子宫颈癌筛查的有效性:基于人群的前瞻性记录数据病例对照研究
BMJ. 2009 Jul 28;339:b2968. doi: 10.1136/bmj.b2968.
3
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
4
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories.不同年龄阶段宫颈筛查的益处:来自英国筛查史审计的证据。
Br J Cancer. 2003 Jul 7;89(1):88-93. doi: 10.1038/sj.bjc.6600974.
5
Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology test: introduction. IARC Working Group on Cervical Cancer Screening.子宫颈鳞状细胞癌筛查——子宫颈细胞学检查结果为阴性后的低风险持续时间:引言。国际癌症研究机构子宫颈癌筛查工作组
IARC Sci Publ. 1986(76):15-24.